Read Along:
It is August 1976. Deep in the equatorial northwest of Zaire, a place the outside world has mostly forgotten, a Belgian nun picks up a glass syringe from a shallow pan of warm water. She draws chloroquine into the barrel. She does not sterilize the needle. She has not sterilized it all day. She will not sterilize it tomorrow.
The Yambuku Mission Hospital owns five syringes. Five needles. For six hundred patients a day. Each needle is rinsed between injections in that same pan of water, and the water is not changed until the pan runs dry.
Today, one of the patients in line is a 44-year-old schoolteacher named Mabalo Lokela. He has a fever. The nun slides the needle into his arm and pushes the plunger. She pulls the needle out, rinses it, and calls the next patient forward.
She does not know that Lokela is carrying something inside him that no human immune system has ever encountered. She does not know that the needle she just rinsed is now coated with it. She does not know that by the end of this month, she will be dead. That three of her fellow nuns will be dead. That the hospital she has given her life to will become the most efficient killing machine in the village.
This is the story of the Ebola virus. Not the movie version. Not the paperback thriller. The real one. And the real one is worse.
Welcome to The Blackmere Podcast. I’m A.M. Blackmere.
There are diseases that kill slowly. Diseases that give you time to bargain, to grieve, to make arrangements. Ebola is not one of them. From the first spike of fever to the final hemorrhage, the window is roughly two weeks. And in those two weeks, the virus executes a sequence of biological events so methodical, so precisely devastating, that it reads less like an infection and more like a coordinated demolition of the human body from the inside out.
But what makes Ebola singular in the catalog of human disease is not just what it does to the body. It is what it does to everything around the body. It turns hospitals into amplifiers. It turns the act of caring for a sick child into a death sentence. It turns the ancient, sacred ritual of washing and burying the dead into a mass casualty event. Ebola weaponizes human compassion. To love someone who has it is to risk becoming it.
In this episode, we go back to the beginning. To a mission hospital in a place called Yambuku, where five glass syringes changed the course of virology forever. We follow the blood sample that arrived in a leaking thermos on a commercial flight to Belgium, where a 27-year-old scientist looked at it under a microscope and saw something no human being had ever seen before. We trace the virus through its forty-year history of eruptions, each one more devastating than the last, until it reached the slums of West Africa and burned through three nations in two years.
And we look at what it does. Precisely. Clinically. Because the horror of Ebola is not in the drama. It is in the mechanism.
Two weeks before Mabalo Lokela walked into the Yambuku Mission Hospital, he had been on a driving excursion through the northern provinces of Zaire, near the border with the Central African Republic. Along the route, he stopped at villages, bought smoked monkey meat and freshly killed antelope from local hunters. He drank locally brewed moonshine called lotoko in a village called Abumombazi. Then he drove home to Yalikonde, a small settlement about a kilometer from the mission complex, and went back to work in the banana plantation.
Nothing about those two weeks was unusual. Bushmeat was a staple protein source across equatorial Africa. The moonshine was a social ritual. The banana plantation was his livelihood between terms at the school. Somewhere in that unremarkable chain of ordinary days, something crossed over. From an animal, through a wound, through a membrane, into his blood.
On September 1, 1976, Lokela presented at the hospital with a headache, a rapid pulse, and a high fever. The medical staff assumed malaria. They gave him a chloroquine injection and sent him home. The fever broke briefly. Then it came back.
By September 5, the headmaster was hemorrhaging from every orifice. Vomiting blood. Severe diarrhea. Chest pain. Intense psychological agitation. His body, as one investigator would later describe it, was coming apart.
He died on September 8. He was 44 years old.
And here is where the story turns from tragedy into catastrophe.
The Yambuku Mission Hospital was founded by Belgian missionaries in 1935. By 1976, it served a region of about sixty thousand people with 120 beds and a staff of seventeen, including a Zairean medical assistant and three Belgian nuns who worked as nurses and midwives. The hospital treated between six thousand and twelve thousand patients every month.
Five glass syringes. Five metal needles. Rinsed in warm water between patients. Not sterilized. Not autoclaved. Rinsed.
In the days after Lokela’s death, dozens of patients who had received routine injections at the hospital developed the same hemorrhagic syndrome. Prenatal patients. Malaria patients. People who had come in for vitamin shots. They bled, they seized, they died. And then their families, who had cared for them at home, began to bleed and seize and die.
The hospital had become an amplifier. Every injection was a direct intravenous delivery of one of the most lethal pathogens on Earth, administered by nuns who believed they were saving lives.
On September 12, one of the Belgian nuns fell ill. The others radioed for help. The provincial physician arrived on September 15, baffled by what he found. By September 19, the sick nun was dead. Within weeks, two more nuns would follow her.
Meanwhile, nearly 500 miles away in Sudan, a parallel nightmare was already unfolding. A quiet storekeeper named Yu G. had fallen ill at a cotton factory in Nzara. The factory was known to be infested with bats and rodents. Yu G. never sought hospital care. He lay in his cot at home, bleeding through his skin, his bedsheets soaked with infectious blood. From Yu G., the virus moved outward through his family and into the hospital in the nearby town of Maridi.
Two outbreaks. Two countries. The same unknown pathogen. And no one on the planet knew what it was.
Three years later, in 1979, the virus would return to the exact same cotton factory in Nzara. As if it remembered the address. Thirty-four people infected. Twenty-two dead. Then silence again. The virus retreated into whatever dark corner of the natural world it had come from, and the world moved on.
But not everyone moved on.
A blood sample drawn from one of the dying nuns was sent to Kinshasa, then forwarded to the Institute of Tropical Medicine in Antwerp, Belgium. It arrived on September 29, 1976, carried in the cockpit of a commercial Sabena Airlines flight.
The container was a blue thermos. The kind you would use to keep coffee warm on a road trip.
Peter Piot was 27 years old. A freshly minted microbiologist. He was part of the small team that received the thermos in the lab. When they pried it open, they found the ice had mostly melted during transit. And one of the glass vials inside had shattered. The scientists fished out the remaining intact tube from a slurry of bloody water and broken glass.
They were wearing latex gloves. Nothing else. No biosafety suits. No respirators. No containment hoods.
Piot would later write about this moment:
A lot more reckless. That is one way to describe handling a pathogen with a 90 percent fatality rate in your bare hands.
They injected the blood into mice and cell cultures, then placed samples under an electron microscope. And when the image resolved, they saw something no one in that lab had ever encountered. A massive, thread-like structure, hundreds of times longer than it was wide, curling back on itself at one end like a shepherd’s crook. It resembled Marburg virus, which they knew. But it was antigenically distinct. It was something new.
An international investigation team deployed to Zaire. Karl Johnson from the CDC. Joel Breman. David Heymann. Peter Piot himself. What they found when they arrived was silence.
In villages like Yalikonde, commerce had stopped. Children were not outside. Entire families had sealed themselves in their homes. The investigators sat with village elders, passing a cup of local arak, listening to oral accounts of a sickness that, as the locals described it, melted the body.
When the international commission met to formally name this new pathogen, Johnson made a deliberate political decision. He would not name it after Yambuku. Naming a lethal virus after a small village would stigmatize its people forever. Instead, he looked at a map and chose a nearby river.
The Ebola River.
The name comes from the local Ngbandi word Legbala. It translates to “white water.” Pure water.
There is something in that. The deadliest virus in modern history, named for purity. Named for clean water. Named for something that cannot hurt you.
The investigators drew a quarantine zone around Yambuku. They closed the hospital. They tracked every known contact. And slowly, over the course of October 1976, the outbreak burned itself out. 318 cases. 280 deaths. An 88 percent fatality rate.
In Sudan, the parallel outbreak claimed 151 out of 284 infected.
Between the two countries, the virus had announced itself to the world. And the world, for the most part, chose to look away. Ebola was a disease of remote African villages. It killed quickly, it burned out quickly, and it stayed far from the cities and airports and stock exchanges that made the West pay attention.
That calculus would hold for nearly forty years. Until it didn’t.
Under an electron microscope, most viruses look roughly spherical. Influenza. HIV. They have a geometric tidiness to them. Ebola looks nothing like them. It appears as a long, tangled filament, sometimes branching, sometimes looping into that characteristic shepherd’s crook shape. Virologists classify it as a filovirus, from the Latin filum, meaning thread.
The shape is not decorative. That elongated surface area allows for devastatingly efficient cellular binding. It is, at the molecular level, a grappling hook. Designed to latch onto human tissue and never let go.
There are six known species. Zaire ebolavirus is the most lethal, with fatality rates between 70 and 90 percent. Sudan ebolavirus kills roughly half of those it infects. Bundibugyo runs around 30 percent. Reston, the one that appeared in a Virginia primate facility in 1989, kills monkeys but leaves humans untouched. A near-miss we will come back to.
But the numbers do not tell the story. The mechanism does.
When Ebola enters the human body, through a cut, a mucous membrane, a contaminated needle, its first act is strategic. It does not attack the lungs. It does not attack the brain. It targets the immune system’s own sentinels. The dendritic cells and macrophages. These are the cells whose entire purpose is to detect foreign invaders, swallow them, and raise the alarm.
Ebola infects them first. It hijacks the alarm system before the alarm can sound.
The virus replicates inside these cells at an extraordinary rate, using them as Trojan horses, riding them directly into the lymph nodes, the liver, the spleen. Meanwhile, it deploys specific proteins, VP24 and VP35, to block the host’s interferon response. Interferon is the body’s emergency broadcast signal. Ebola cuts the wire.
So the immune system is blind. The virus is multiplying unchecked. And the infected cells, now swollen with new viral particles, begin to die.
But they do not die quietly. When they burst open, they release a massive flood of inflammatory molecules into the bloodstream. Tumor necrosis factor. Interleukin. Reactive oxygen species. The body’s own immune response, now unregulated and directionless, turns inward. This is the cytokine storm. And it is the point where the disease stops being an infection and becomes a demolition.
The cytokine storm attacks the walls of the blood vessels. The tight junctions between endothelial cells, the cells that line every vein and artery and capillary in the body, begin to separate. The circulatory system starts to leak.
And here is where the biology becomes a paradox that reads like fiction, except that it is not.
The virus forces the body to activate its entire coagulation cascade at once. Millions of tiny blood clots form simultaneously throughout the bloodstream, lodging in capillaries, choking off oxygen to organs, killing tissue in patches. This is called disseminated intravascular coagulation. DIC. The body is clotting everywhere.
But because all the clotting factors have been consumed by those millions of micro-clots, the blood loses its ability to clot at all. The patient begins to hemorrhage. From the gums. The eyes. The nose. Internally, from the stomach and intestines.
Clotting to death and bleeding to death at the same time. That is not a metaphor. That is the clinical description.
And there is another dimension to this horror that operates entirely in the mind. The incubation period. Two to twenty-one days. Three weeks of not knowing.
A person can care for a dying parent, wash the blood from their sheets, hold their hand as they seize, and then walk away feeling perfectly fine. For days. For a week. For two weeks. And the whole time, the virus may or may not be replicating inside them, working its way through the immune sentinels, building toward the cytokine storm that will tear them apart.
Every headache becomes a question. Every muscle ache. Every degree of temperature. Is this it? Is this the fever? Or is this just exhaustion from burying your mother?
The incubation period turns the human body into a locked room. And you do not get to know what is inside until the door opens.
In the final stage, the organs fail in sequence. The liver undergoes massive necrosis. The kidneys shut down. The spleen hardens into a mass of dead blood cells. Terminal patients in the last 24 to 48 hours often vomit a black fluid that medical staff describe as resembling coffee grounds. It is composed of sloughed intestinal lining and digested blood. Seizures. Delirium. Coma. Death.
That is what the clinical literature describes. But the clinical literature is written in the passive voice, at a distance. It does not tell you what it is like to be inside that body.
We know what it is like. Because some people survived it. And they told us.
Dr. Jean-Jacques Muyembe, one of the first Congolese scientists to investigate Ebola, described the simple act of drawing blood from a patient:
“I was immediately struck by the fact that when I removed the syringe from the site of the puncture wound it bled profusely. My fingers and hands were soiled with blood.”
His fingers. Soiled with the blood of a patient whose clotting factors had been entirely consumed. Every healthcare worker who has treated Ebola describes the same ambient terror. The fear of a pinprick. A torn glove. An accidental brush of a hand against an exposed surface. One mistake, in one moment of exhaustion, and you cross from caregiver to patient.
Dr. Adaora Igonoh was a Nigerian physician who contracted Ebola while treating the Liberian index case in Lagos. She wrote about the isolation ward:
“I was kept in a room that stank of depression... I battled for my life while watching patients die one by one next to me. Was it my turn? I could not accept that. The fever was weakening me. The constant diarrhea was degrading enough to make me wear adult diapers. The vomitus was so bitter that it made me want to vomit even more.”
She watched her fellow patients lose themselves. She described them as having a “zombie look.” Very aloof. A little scary. As though they were not present in their bodies.
And she described the isolation. The total removal of human touch. Every caregiver hidden behind layers of rubber and plastic.
“It felt like I was a dangerous alien from whom people needed protection.”
Patrick Trye, a medical coordinator for Doctors Without Borders in Sierra Leone, also contracted the virus. His first thought upon diagnosis:
“My turn to go has come. I am going to die.”
While in the treatment center, a female colleague told him she was hopeful she would survive. She died two days later. He carried that with him.
And then there is Dr. Ian Crozier, an American physician who survived Ebola in Sierra Leone. Months after his discharge, months after his blood tested negative, a severe inflammation developed in his left eye. When ophthalmologists inserted a needle into the aqueous humor, they found it teeming with live Ebola virus. And the iris of his eye had changed color. From blue to a vivid, glowing green.
The virus was still inside him. Hiding in a place the immune system could not reach.
And this persistence is not limited to the eyes. Ebola has been found in semen up to fifteen months after recovery. In breast milk. In spinal fluid. A survivor can test negative in their blood, be declared cured, walk out of the treatment center, and still carry the virus in the most intimate parts of their body. Still transmit it to a partner. Still give it to a nursing child.
To survive Ebola is not necessarily to be free of it.
And even for those who clear the virus entirely, the aftermath is brutal. Post-Ebola Syndrome. Chronic joint pain. Vision problems. Neurological damage. And then there is the social death. Survivors from the 2014 epidemic were fired from their jobs, abandoned by their spouses, rejected by their own villages. A woman named Chantal, from the Democratic Republic of the Congo, described what happened when she returned home after recovery:
“People began to avoid me. At the market, some even refused to take my money, afraid of being infected. Before the disease, I ran a small restaurant. No one comes anymore... I am cured, but pushed aside.”
Cured, but pushed aside. That is the sentence that stays with me.
There is one more thing about the biology that matters for the story ahead. A human body killed by Ebola is at peak viral load at the moment of death. The corpse is, biologically speaking, more dangerous than the living patient. It seeps virus-laden fluids from every surface. And across West and Central Africa, the sacred burial tradition requires the family to wash the body, dress it, hold it, prepare it for passage to the afterlife. The last act of love. Transformed by the virus into a mass casualty event.
For nearly two decades after 1976, Ebola remained a disease of the deep equatorial forest. Small outbreaks. Remote villages. Terrible mortality, but contained. The virus burned too hot and too fast to spread far before it ran out of victims.
In 1994, Ebola surfaced in the rainforests of Gabon, striking remote gold-panning encampments deep in the jungle. Miners began dying of a hemorrhagic illness. At the same time, epidemiologists noticed something eerie. Wild chimpanzee and gorilla populations in the surrounding forest were dying too. In one incident, thirteen people fell violently ill after finding a dead chimpanzee and butchering its carcass for meat. The virus was not just in humans. It was moving through the primate world in parallel, burning through populations that had no more defense against it than we did.
Then came Kikwit.
In April 1995, a 36-year-old laboratory technician named Kimfumu fell ill in the city of Kikwit, Zaire. Severe fever. Abdominal distress. The doctors at Kikwit General Hospital suspected a perforated ulcer or severe typhoid. They wheeled him into the operating room and opened his abdomen.
What they found inside was not an ulcer.
The patient’s internal organs were actively dissolving. He hemorrhaged uncontrollably across the surgical drapes, spraying aerosolized blood into the faces and lungs of the entire surgical team.
Kimfumu died two days later. But the damage was done. The entire surgical team fell ill. The Italian Poverelle nuns who administered the hospital began to die in rapid succession. Sister Floralba Rondi, who had assisted in the surgery, was first. Her body was transported to the local cathedral for an open-casket viewing. Hundreds of mourners wept over her, touching her face.
Within weeks, Sisters Clarangela, Danielangela, and Dinarosa were all dead. Bleeding out in the wards they had once managed.
The Kikwit outbreak killed 254 people out of 315 infected. It was only halted when the Zairean military cordoned off the entire city, trapping the infected inside.
Five years later, in the fall of 2000, the Sudan strain struck the Gulu district of Uganda. At the center of the response was a physician named Dr. Matthew Lukwiya, who ran St. Mary’s Hospital Lacor.
Lukwiya identified the disease quickly. He established a rigorous isolation ward staffed entirely by volunteers. But the work was crushing. Fourteen-hour shifts in full PPE, in un-air-conditioned equatorial heat. Sweat pooling in rubber boots. Condensation blinding goggles. And patients dying faster than they could be treated.
On November 24, his staff of 400 mutinied. They gathered in the hospital courtyard and demanded the facility be closed immediately. Lukwiya walked out to face them. He told them he would rather die in this hospital than abandon his patients. Through sheer moral conviction, he persuaded them to go back to the wards.
Days later, a dying nurse in isolation tore off his oxygen mask in a fit of terminal delirium and coughed a heavy spray of blood into the hallway. Lukwiya was woken from a brief sleep to assist. In his groggy haste, he pulled on his gowns, gloves, aprons, and mask. He forgot his goggles.
On December 5, 2000, as his lungs filled with blood, Dr. Matthew Lukwiya died. His final words, whispered to the colleagues at his bedside:
“Oh, God, I think I will die in my service. If I die, let me be the last.”
He was not the last. The Gulu outbreak killed 224 people. But his sacrifice defined what it meant to fight this disease. And it foreshadowed the scale of what was coming.
In December 2013, in a remote Guinean village called Meliandou, a two-year-old boy named Emile Ouamouno began to bleed and seize. He died on December 28.
Epidemiologists would later discover a hollow, burned-out tree near his home. When the tree had caught fire weeks earlier, villagers reported a rain of bats pouring from the burning trunk. Emile had played inside that hollow tree.
From a single toddler, in a single village, the worst Ebola outbreak in history began.
This time, the virus did not stay in the forest. It crossed porous borders into Liberia and Sierra Leone. It reached the urban slums of Monrovia, Freetown, and Conakry. Weak healthcare systems, decades of civil war, and deep cultural distrust of foreign medical teams acted as accelerant. The World Health Organization was catastrophically slow to respond. Doctors Without Borders sounded the alarm in early 2014, calling the outbreak unprecedented. They were ignored for three months.
In Monrovia, the ELWA 3 treatment center exceeded its 250-bed capacity. Doctors were forced into an agonizing triage. They turned infectious patients away at the gates. Not because they did not care. Because there was physically no room. Reporters documented dying people vomiting blood in the back seats of taxis, abandoned by terrified drivers, left to die in the streets or crawl home to infect their families.
Clinics across the region closed as healthcare workers died by the hundreds. Entire neighborhoods were sealed off. Schools shuttered. Markets emptied. Liberian burial teams, tasked with collecting infectious corpses from slums and homes, worked in unbearable conditions, facing social stigma, physical danger, and the constant risk that the next body they zipped into a bag would be the one that killed them.
And in the communities, fear and distrust metastasized alongside the virus. In some villages, the word “isolation center” was heard as “death chamber.” Families hid their sick from medical teams. In the village of Womey, in southeast Guinea, a team of health workers and journalists were stoned to death by residents who believed the outsiders were bringing the disease, not fighting it. The conspiracy theories spread as fast as the virus itself. Claims that Ebola was fabricated by Western governments to harvest organs. That NGOs invented the crisis to access aid money. In Nigeria, at least two people died after drinking large quantities of salt water, a rumored miracle cure that spread through social media.
Esther, a survivor from the Democratic Republic of the Congo, lost her husband to the virus. She was not allowed to be with him when he died.
“I stayed with my husband until his last day, but not until his last breath... The doctors wanted me to leave because the situation was so serious... I stayed outside, unable to go back in, worried knowing he was alone. Around 10 p.m., they came to tell me he had passed away... That night, I cried without stopping, outside the hospital, inconsolable.”
She could not hold his hand. Could not touch his face. Could not sit beside him as he went. Because to do any of those things would have meant joining him.
That is Ebola’s cruelest trick. It does not just kill the body. It poisons the space between people. It makes the act of comfort into the act of transmission. It punishes you for loving someone.
Over two years, the West African epidemic infected more than 28,600 people and killed more than 11,300. Nearly 500 of the dead were healthcare workers. And that is only the direct toll. As hospitals shut down, thousands more died of untreated malaria, complications during childbirth, tuberculosis. Diseases that were treatable, survivable, if anyone had been left to treat them. The economies of Guinea, Liberia, and Sierra Leone lost an estimated $30 to $50 billion. Agricultural fields lay fallow. An entire generation of children lost months or years of schooling.
The virus did not just kill people. It dismantled societies.
The epidemic also proved that Ebola could board a plane. Thomas Eric Duncan, a Liberian national, became the first person diagnosed with Ebola on American soil after arriving in Dallas, Texas. He died. Two of his nurses were infected. Cases appeared in Madrid and New York. The Western world, which had largely ignored Ebola for four decades, suddenly panicked.
But the single most consequential moment of the entire epidemic happened not in Dallas or New York. It happened in Lagos.
In July 2014, Patrick Sawyer, an infected Liberian-American diplomat, boarded a commercial flight and collapsed upon landing in Lagos, Nigeria. A chaotic city of over twenty million people. If the virus had established sustained transmission in Lagos, the models showed potential for a continental catastrophe.
Sawyer was taken to the First Consultant Medical Centre, where an attending physician named Dr. Stella Ameyo Adadevoh immediately suspected Ebola. Sawyer was aggressive, desperate to leave. The Liberian government and the ECOWAS ambassador pressured the hospital to release him to attend a conference. When Adadevoh refused, Sawyer tore out his intravenous line and deliberately sprayed his infectious blood across the isolation room and onto the medical staff.
Adadevoh held her ground. She physically confined him. She told colleagues it was for the greater public good.
Her stand saved Lagos. It likely saved the African continent from an unimaginable escalation. Nigeria’s rapid response, built on her decision, limited the outbreak to 19 cases and 7 deaths. Epidemiologists call it one of the most consequential saves in modern history.
Dr. Stella Ameyo Adadevoh contracted the virus from Sawyer’s blood. She died in isolation a few weeks later. The woman who saved a megacity of twenty million people died alone, behind plastic sheeting, in the same hospital where she made her stand.
And the virus continued to find new ground. In 2018, the Zaire strain struck North Kivu province in the DRC, an active war zone. Armed rebel groups attacked treatment centers. In April 2019, gunmen stormed a hospital during an Ebola response meeting and shot Dr. Richard Valery Mouzoko Kiboung, a WHO epidemiologist, in the stomach. He died. The outbreak lasted two years, killed over 2,200 people, and proved that the only thing more dangerous than a hemorrhagic fever is a hemorrhagic fever in a place where the population has already lost trust in every institution that might save them.
During the 2014 epidemic, genetic sequencing of the circulating virus revealed something that made virologists go quiet. A mutation. Designated A82V. A change in the viral envelope glycoprotein that made the virus significantly more efficient at infecting human cells, while simultaneously reducing its affinity for bat cells.
The virus was adapting. In real time. Learning, through the blind mechanics of natural selection, how to become a better killer of human beings.
Earlier, I mentioned the Reston strain. The near-miss. In the fall of 1989, macaque monkeys imported from the Philippines began dying rapidly and mysteriously at a commercial primate quarantine facility in Reston, Virginia. Miles from the Capitol. The U.S. Army Medical Research Institute of Infectious Diseases confirmed the presence of a filovirus. Fearing the Zaire strain had reached American soil, a military bio-containment team mobilized. To avoid mass panic, soldiers arrived in unmarked civilian clothes, changing into pressurized hazmat suits only once inside the building and out of public view.
They spent days in dimly lit rooms slick with blood and primate feces, euthanizing the remaining animals. Then the blood tests came back. Four human animal handlers had been exposed. They tested positive for the virus.
By an accident of evolution, Reston ebolavirus turned out to be lethal to monkeys but harmless to humans. The four handlers never developed symptoms. Had it been the Zaire strain, the Washington metropolitan area would have faced something out of a disaster film. And it happened five years before most Americans had ever heard the word Ebola.
And we still do not know where it hides between outbreaks. Not definitively. Fruit bats are the primary suspects. Species like Hypsignathus monstrosus and Epomops franqueti have tested positive for antibodies. But no one has ever pulled a live Ebola virus from a wild bat. The reservoir remains a theory. A very strong theory. But a theory.
What we do know is that the conditions for future spillovers are getting worse. Deforestation across Central and West Africa pushes human settlements deeper into the ecosystems where those bats live. Climate change alters migration patterns, forcing wildlife into new overlaps with human populations. Every hectare of cleared forest is a new point of contact between a species that carries the virus and a species that cannot survive it.
And then there is this.
During the Cold War, the Soviet biological weapons program known as Biopreparat successfully weaponized Ebola for deployment in intercontinental ballistic missiles. According to Dr. Ken Alibek, the former deputy director who defected to the United States, Soviet scientists at the Vector Institute attempted something even more ambitious. They called it the Chimera Project. The goal was to genetically splice Ebola with smallpox. A pathogen that could spread through the air like smallpox and destroy the body like Ebola. The program was officially dismantled when the Soviet Union collapsed. The fate of those engineered strains, and the scientists who created them, remains unknown.
I keep coming back to the hollow tree in Meliandou. The one where Emile Ouamouno played. When it caught fire, a rain of bats poured out of the trunk. A two-year-old boy, crawling into a dark, hollow space full of creatures carrying something his species had no defense against.
The tree is gone now. Burned to a stump.
But the bats are not gone. The virus is not gone. It circulates silently in the canopy, in caves, in colonies roosting under the eaves of tin-roofed villages, waiting for the next contact. The next child who reaches into the wrong shadow. The next hunter who cuts into the wrong carcass. The next nurse who picks up the wrong syringe.
Ebola is patient. It does not need to evolve. It does not need to become airborne. It simply needs us to keep doing what we have always done. To keep pushing deeper into the places where it lives. To keep being human. Compassionate. Reckless.
And it will be waiting.
I’m A.M. Blackmere. Thank you for listening.
